data_1iyu_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1iyu _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.406 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 99.4 p . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.437 -0.579 . . . . 2.27 109.437 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -129.6 147.48 51.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.269 -0.894 . . . . 2.7400000000000002 109.463 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.1 mt -89.43 141.15 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.247 -0.908 . . . . 2.6899999999999999 109.468 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.4 mt -113.26 104.33 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.227 -0.921 . . . . 2.3599999999999999 109.503 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 2.5 ptt180 -90.81 179.83 5.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.259 -0.901 . . . . 3.0899999999999999 109.426 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.46 ' HB ' ' HA ' ' A' ' 65' ' ' GLU . 53.7 t -66.09 139.51 96.6 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.217 -0.927 . . . . 1.4299999999999999 109.401 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.46 ' HD2' HG12 ' A' ' 6' ' ' VAL . 35.5 Cg_endo -78.2 -170.32 0.95 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.739 2.293 . . . . 1.2 110.407 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -83.2 108.55 16.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.881 . . . . 1.74 109.4 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.432 HD12 HG22 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -107.69 -30.41 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.255 -0.903 . . . . 2.2000000000000002 109.4 -179.928 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.05 10.67 54.64 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.545 -1.422 . . . . 1.5600000000000001 109.545 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -170.87 -152.1 7.97 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.515 -1.434 . . . . 1.3500000000000001 109.515 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -93.32 150.54 20.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -1.152 . . . . 2.2200000000000002 109.444 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -117.69 112.92 2.55 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.541 -1.423 . . . . 0.89000000000000001 109.541 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.502 ' CG ' ' HG2' ' A' ' 62' ' ' LYS . 1.3 mt-10 -99.64 127.79 45.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.247 -1.149 . . . . 2.6200000000000001 109.428 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.3 t -70.51 131.36 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.224 -0.923 . . . . 1.29 109.462 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.404 ' HB ' ' O ' ' A' ' 34' ' ' VAL . 20.8 mm -102.06 -52.62 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 2.3700000000000001 109.472 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -145.8 164.07 33.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -0.9 . . . . 2.5600000000000001 109.456 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.411 HD22 HG21 ' A' ' 20' ' ' VAL . 0.4 OUTLIER -127.14 114.81 18.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.332 -0.855 . . . . 2.1299999999999999 109.474 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.97 36.64 2.16 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.272 -0.892 . . . . 1.78 109.492 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.413 HG13 ' HG ' ' A' ' 32' ' ' LEU . 11.6 m -138.6 172.16 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.254 -0.904 . . . . 1.6399999999999999 109.482 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -146.71 176.85 9.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.277 -0.889 . . . . 3.2000000000000002 109.479 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.1 m -85.03 134.55 34.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.285 -0.884 . . . . 2.1200000000000001 109.466 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.61 -2.57 87.92 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.647 -1.381 . . . . 0.96999999999999997 109.647 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -84.97 131.54 34.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.211 -1.17 . . . . 1.52 109.507 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.18 121.77 30.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.253 -0.904 . . . . 2.46 109.452 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.506 ' CD1' HD13 ' A' ' 32' ' ' LEU . 3.8 mt -94.05 -170.74 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 121.213 -0.93 . . . . 1.3999999999999999 109.355 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.408 ' H ' ' CG2' ' A' ' 26' ' ' ILE . 28.0 mt-10 -140.81 168.18 20.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.22 -0.925 . . . . 2.9300000000000002 109.481 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.537 ' O ' ' CB ' ' A' ' 29' ' ' GLU . 10.1 p -79.82 76.67 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.884 . . . . 1.96 109.439 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.537 ' CB ' ' O ' ' A' ' 28' ' ' VAL . 0.9 OUTLIER 161.53 -48.23 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.286 -0.884 . . . . 2.6299999999999999 109.457 179.945 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.416 ' O ' ' CB ' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -52.96 145.57 12.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.223 -0.923 . . . . 2.1800000000000002 109.465 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 45' ' ' PRO . . . -68.44 167.74 43.53 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.535 -1.426 . . . . 0.81999999999999995 109.535 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.506 HD13 ' CD1' ' A' ' 26' ' ' ILE . 0.2 OUTLIER -128.41 -48.24 1.3 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -1.137 . . . . 2.3199999999999998 109.505 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.446 HG11 ' O ' ' A' ' 32' ' ' LEU . 34.6 m -145.68 171.25 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.294 -0.879 . . . . 1.3500000000000001 109.509 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.404 ' O ' ' HB ' ' A' ' 16' ' ' ILE . 95.9 t -128.34 92.38 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.278 -0.889 . . . . 1.3100000000000001 109.467 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.446 ' CD1' HG22 ' A' ' 44' ' ' VAL . 1.1 mt -90.02 146.55 24.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 1.8 109.453 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 41' ' ' SER . 35.9 tt0 -108.62 144.73 35.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -0.906 . . . . 2.27 109.473 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 40' ' ' ALA . 1.5 m -105.96 -173.79 2.38 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.281 -0.887 . . . . 1.8999999999999999 109.46 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.467 ' O ' ' HG3' ' A' ' 39' ' ' LYS . . . -85.02 -4.42 59.15 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.258 -0.901 . . . . 2.0699999999999998 109.694 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.531 ' O ' ' CB ' ' A' ' 40' ' ' ALA . 22.2 mtpp -150.15 20.55 0.86 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.181 -0.95 . . . . 5.4699999999999998 109.679 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.531 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . 163.85 137.65 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.117 -0.99 . . . . 1.96 109.55 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 36' ' ' GLU . 0.7 OUTLIER -95.58 133.58 39.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 1.98 109.466 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 8.8 mtt -117.63 157.09 27.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.9 . . . . 3.6499999999999999 109.451 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -114.77 154.62 28.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.283 -0.886 . . . . 2.1099999999999999 109.449 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.496 ' O ' ' CB ' ' A' ' 32' ' ' LEU . 21.7 t -130.64 110.74 16.12 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.293 -0.879 . . . . 1.72 109.37 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.477 ' HA ' ' N ' ' A' ' 32' ' ' LEU . 35.6 Cg_endo -77.82 -168.32 0.59 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.629 2.219 . . . . 0.89000000000000001 110.47 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.483 ' HA ' ' CD1' ' A' ' 32' ' ' LEU . 2.0 t -85.17 120.79 73.78 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 1.02 109.537 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.02 -0.5 10.73 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.636 2.224 . . . . 1.3100000000000001 110.291 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.455 ' O ' HD12 ' A' ' 72' ' ' LEU . 0.6 OUTLIER -160.14 138.5 10.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.364 -0.835 . . . . 3.5499999999999998 109.396 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -80.48 92.2 5.85 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.224 -0.922 . . . . 1.72 109.463 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -142.83 -164.55 10.22 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.548 -1.421 . . . . 1.3899999999999999 109.548 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.413 ' O ' ' C ' ' A' ' 52' ' ' VAL . 7.8 p -117.24 122.68 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.262 -1.14 . . . . 1.54 109.496 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.413 ' C ' ' O ' ' A' ' 51' ' ' VAL . 72.8 t -44.11 137.71 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.269 -0.894 . . . . 1.3400000000000001 109.432 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.417 ' HD2' ' OE1' ' A' ' 73' ' ' GLU . 14.1 tttp -113.72 -41.14 3.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.918 . . . . 2.9300000000000002 109.45 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.64 144.37 17.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.236 -0.915 . . . . 2.0699999999999998 109.472 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.449 HG13 ' O ' ' A' ' 57' ' ' VAL . 39.7 t -106.42 111.72 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.307 -0.871 . . . . 1.51 109.457 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.3 m -90.2 17.15 7.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.213 -0.929 . . . . 1.8400000000000001 109.448 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.484 ' CG1' HD12 ' A' ' 63' ' ' LEU . 28.6 m -140.61 179.85 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.896 . . . . 1.6000000000000001 109.493 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -141.93 175.03 10.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.304 -0.873 . . . . 3.6299999999999999 109.508 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.84 129.43 34.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.254 -0.904 . . . . 1.78 109.494 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.26 -11.46 72.08 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.511 -1.436 . . . . 0.93000000000000005 109.511 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.83 157.06 35.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -1.148 . . . . 1.52 109.495 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.502 ' HG2' ' CG ' ' A' ' 14' ' ' GLU . 25.6 mtpt -106.63 143.62 34.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.276 -0.89 . . . . 3.8999999999999999 109.47 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.484 HD12 ' CG1' ' A' ' 57' ' ' VAL . 3.7 mt -140.89 141.81 34.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 2.52 109.513 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.455 ' O ' ' C ' ' A' ' 65' ' ' GLU . 1.7 tttt -98.66 140.73 32.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.271 -0.893 . . . . 2.8900000000000001 109.47 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.46 ' HA ' ' HB ' ' A' ' 6' ' ' VAL . 9.7 pt-20 -41.13 139.77 0.9 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.327 -0.858 . . . . 2.6099999999999999 109.634 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.41 -15.72 59.77 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.547 -1.421 . . . . 1.0900000000000001 109.547 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.06 140.32 31.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.212 -1.169 . . . . 1.4299999999999999 109.5 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.96 150.79 41.35 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.217 -0.927 . . . . 1.3 109.41 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.473 HD11 HG22 ' A' ' 69' ' ' ILE . 28.1 mm -115.04 -66.39 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.206 -0.934 . . . . 1.95 109.456 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.404 HG22 HG21 ' A' ' 69' ' ' ILE . 1.2 pt -142.43 177.1 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.286 -0.884 . . . . 1.75 109.46 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -129.85 104.72 7.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.18 -0.95 . . . . 2.1299999999999999 109.446 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.492 HD22 ' N ' ' A' ' 74' ' ' PRO . 2.8 tt -90.0 144.01 26.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.232 -0.917 . . . . 1.9399999999999999 109.404 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.417 ' OE1' ' HD2' ' A' ' 53' ' ' LYS . 46.9 tt0 -112.21 94.65 27.06 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.271 -0.893 . . . . 2.1800000000000002 109.457 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.492 ' N ' HD22 ' A' ' 72' ' ' LEU . 35.6 Cg_endo -77.64 78.58 3.47 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.743 2.296 . . . . 2.02 110.428 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -45.96 98.24 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.255 -0.903 . . . . 2.75 109.493 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 74' ' ' PRO . . . -86.13 58.45 5.06 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.891 . . . . 4.2199999999999998 109.436 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.515 ' O ' ' N ' ' A' ' 79' ' ' ARG . . . 88.44 -64.73 3.47 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.474 -1.451 . . . . 4.8300000000000001 109.474 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 47.49 -93.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.252 -1.146 . . . . 6.9199999999999999 109.451 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.515 ' N ' ' O ' ' A' ' 77' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 118.038 -0.982 . . . . 11.34 109.441 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.437 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 99.4 p . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.437 -0.579 . . . . 1.86 109.437 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -129.6 147.48 51.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.269 -0.894 . . . . 2.74 109.463 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.1 mt -89.43 141.15 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.247 -0.908 . . . . 2.24 109.468 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.4 mt -113.26 104.33 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.227 -0.921 . . . . 1.76 109.503 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 2.5 ptt180 -90.81 179.83 5.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.259 -0.901 . . . . 2.66 109.426 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.948 HG23 HD11 ' A' ' 69' ' ' ILE . 53.7 t -66.09 139.51 96.6 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.217 -0.927 . . . . 0.86 109.401 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.661 ' HD2' HG13 ' A' ' 6' ' ' VAL . 35.5 Cg_endo -78.2 -170.32 0.95 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.739 2.293 . . . . 1.04 110.407 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -83.2 108.55 16.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.881 . . . . 1.74 109.4 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.596 HD11 HG11 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -107.69 -30.41 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.255 -0.903 . . . . 1.68 109.4 -179.928 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.05 10.67 54.64 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.545 -1.422 . . . . 1.4 109.545 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -170.87 -152.1 7.97 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.515 -1.434 . . . . 1.35 109.515 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.402 ' OD1' ' HG3' ' A' ' 64' ' ' LYS . 2.1 m-20 -93.32 150.54 20.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -1.152 . . . . 2.22 109.444 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -117.69 112.92 2.55 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.541 -1.423 . . . . 0.82 109.541 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.516 ' CG ' ' HG2' ' A' ' 62' ' ' LYS . 1.3 mt-10 -99.64 127.79 45.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.247 -1.149 . . . . 2.62 109.428 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.3 t -70.51 131.36 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.224 -0.923 . . . . 0.64 109.462 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.41 ' HB ' ' O ' ' A' ' 34' ' ' VAL . 20.8 mm -102.06 -52.62 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 1.82 109.472 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -145.8 164.07 33.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -0.9 . . . . 2.56 109.456 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.14 114.81 18.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.332 -0.855 . . . . 1.59 109.474 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.456 HD11 ' C ' ' A' ' 31' ' ' GLY . 0.4 OUTLIER -102.97 36.64 2.16 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.272 -0.892 . . . . 1.26 109.492 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.682 HG11 ' HG ' ' A' ' 32' ' ' LEU . 11.6 m -138.6 172.16 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.254 -0.904 . . . . 1.12 109.482 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -146.71 176.85 9.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.277 -0.889 . . . . 2.68 109.479 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.1 m -85.03 134.55 34.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.285 -0.884 . . . . 1.56 109.466 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.61 -2.57 87.92 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.647 -1.381 . . . . 0.97 109.647 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -84.97 131.54 34.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.211 -1.17 . . . . 1.52 109.507 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.674 HD12 ' HB ' ' A' ' 51' ' ' VAL . 0.4 OUTLIER -87.18 121.77 30.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.253 -0.904 . . . . 1.93 109.452 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.752 HG22 ' H ' ' A' ' 27' ' ' GLU . 3.8 mt -94.05 -170.74 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 121.213 -0.93 . . . . 1.06 109.355 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.752 ' H ' HG22 ' A' ' 26' ' ' ILE . 28.0 mt-10 -140.81 168.18 20.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.22 -0.925 . . . . 2.93 109.481 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.733 HG13 ' O ' ' A' ' 28' ' ' VAL . 10.1 p -79.82 76.67 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.884 . . . . 1.5 109.439 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.537 ' CB ' ' O ' ' A' ' 28' ' ' VAL . 0.9 OUTLIER 161.53 -48.23 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.286 -0.884 . . . . 2.63 109.457 179.945 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.416 ' O ' ' CB ' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -52.96 145.57 12.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.223 -0.923 . . . . 2.18 109.465 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.456 ' C ' HD11 ' A' ' 19' ' ' LEU . . . -68.44 167.74 43.53 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.535 -1.426 . . . . 0.74 109.535 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.682 ' HG ' HG11 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -128.41 -48.24 1.3 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -1.137 . . . . 1.71 109.505 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.6 m -145.68 171.25 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.294 -0.879 . . . . 0.81 109.509 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.41 ' O ' ' HB ' ' A' ' 16' ' ' ILE . 95.9 t -128.34 92.38 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.278 -0.889 . . . . 0.71 109.467 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 mt -90.02 146.55 24.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 1.21 109.453 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 41' ' ' SER . 35.9 tt0 -108.62 144.73 35.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -0.906 . . . . 2.27 109.473 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 40' ' ' ALA . 1.5 m -105.96 -173.79 2.38 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.281 -0.887 . . . . 1.62 109.46 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.486 ' O ' ' HG3' ' A' ' 39' ' ' LYS . . . -85.02 -4.42 59.15 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.258 -0.901 . . . . 1.87 109.694 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.703 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 22.2 mtpp -150.15 20.55 0.86 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.181 -0.95 . . . . 5.09 109.679 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 39' ' ' LYS . . . 163.85 137.65 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.117 -0.99 . . . . 1.48 109.55 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.484 ' HA ' ' HA ' ' A' ' 36' ' ' GLU . 0.7 OUTLIER -95.58 133.58 39.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 1.65 109.466 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 8.8 mtt -117.63 157.09 27.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.9 . . . . 3.21 109.451 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -114.77 154.62 28.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.283 -0.886 . . . . 2.11 109.449 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.496 ' O ' ' CB ' ' A' ' 32' ' ' LEU . 21.7 t -130.64 110.74 16.12 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.293 -0.879 . . . . 1.19 109.37 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.501 ' HA ' ' N ' ' A' ' 32' ' ' LEU . 35.6 Cg_endo -77.82 -168.32 0.59 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.629 2.219 . . . . 0.82 110.47 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.538 ' HB2' HG21 ' A' ' 26' ' ' ILE . 2.0 t -85.17 120.79 73.78 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 0.95 109.537 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.02 -0.5 10.73 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.636 2.224 . . . . 1.31 110.291 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -160.14 138.5 10.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.364 -0.835 . . . . 3.13 109.396 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -80.48 92.2 5.85 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.224 -0.922 . . . . 1.43 109.463 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.731 ' N ' HD11 ' A' ' 72' ' ' LEU . . . -142.83 -164.55 10.22 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.548 -1.421 . . . . 1.2 109.548 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.674 ' HB ' HD12 ' A' ' 25' ' ' LEU . 7.8 p -117.24 122.68 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.262 -1.14 . . . . 1.08 109.496 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.413 ' C ' ' O ' ' A' ' 51' ' ' VAL . 72.8 t -44.11 137.71 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.269 -0.894 . . . . 0.79 109.432 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.413 ' HD2' ' OE1' ' A' ' 73' ' ' GLU . 14.1 tttp -113.72 -41.14 3.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.918 . . . . 2.49 109.45 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.64 144.37 17.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.236 -0.915 . . . . 1.67 109.472 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.54 HG12 ' H ' ' A' ' 57' ' ' VAL . 39.7 t -106.42 111.72 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.307 -0.871 . . . . 0.96 109.457 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.3 m -90.2 17.15 7.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.213 -0.929 . . . . 1.4 109.448 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.54 ' H ' HG12 ' A' ' 55' ' ' VAL . 28.6 m -140.61 179.85 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.896 . . . . 1.12 109.493 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -141.93 175.03 10.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.304 -0.873 . . . . 3.16 109.508 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.84 129.43 34.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.254 -0.904 . . . . 1.2 109.494 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.26 -11.46 72.08 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.511 -1.436 . . . . 0.84 109.511 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.83 157.06 35.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -1.148 . . . . 1.52 109.495 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.516 ' HG2' ' CG ' ' A' ' 14' ' ' GLU . 25.6 mtpt -106.63 143.62 34.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.276 -0.89 . . . . 3.49 109.47 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 62' ' ' LYS . 3.7 mt -140.89 141.81 34.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 2.0 109.513 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.455 ' O ' ' C ' ' A' ' 65' ' ' GLU . 1.7 tttt -98.66 140.73 32.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.271 -0.893 . . . . 2.42 109.47 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.476 ' HA ' ' HB ' ' A' ' 6' ' ' VAL . 9.7 pt-20 -41.13 139.77 0.9 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.327 -0.858 . . . . 2.61 109.634 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.41 -15.72 59.77 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.547 -1.421 . . . . 0.95 109.547 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.06 140.32 31.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.212 -1.169 . . . . 1.43 109.5 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.96 150.79 41.35 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.217 -0.927 . . . . 0.7 109.41 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.948 HD11 HG23 ' A' ' 6' ' ' VAL . 28.1 mm -115.04 -66.39 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.206 -0.934 . . . . 1.3 109.456 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.403 HG23 HG22 ' A' ' 69' ' ' ILE . 1.2 pt -142.43 177.1 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.286 -0.884 . . . . 1.23 109.46 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -129.85 104.72 7.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.18 -0.95 . . . . 2.13 109.446 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.84 HD23 ' HD3' ' A' ' 74' ' ' PRO . 2.8 tt -90.0 144.01 26.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.232 -0.917 . . . . 1.41 109.404 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.413 ' OE1' ' HD2' ' A' ' 53' ' ' LYS . 46.9 tt0 -112.21 94.65 27.06 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.271 -0.893 . . . . 2.18 109.457 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.84 ' HD3' HD23 ' A' ' 72' ' ' LEU . 35.6 Cg_endo -77.64 78.58 3.47 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.743 2.296 . . . . 2.02 110.428 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -45.96 98.24 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.255 -0.903 . . . . 2.24 109.493 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 74' ' ' PRO . . . -86.13 58.45 5.06 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.891 . . . . 3.79 109.436 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.515 ' O ' ' N ' ' A' ' 79' ' ' ARG . . . 88.44 -64.73 3.47 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.474 -1.451 . . . . 4.83 109.474 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 47.49 -93.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.252 -1.146 . . . . 6.6 109.451 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.515 ' N ' ' O ' ' A' ' 77' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 118.038 -0.982 . . . . 10.79 109.441 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.437 ' HA ' ' HD2' ' A' ' 74' ' ' PRO . 99.4 p . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.437 -0.579 . . . . 1.8600000000000001 109.437 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -129.6 147.48 51.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.269 -0.894 . . . . 2.7400000000000002 109.463 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.1 mt -89.43 141.15 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.247 -0.908 . . . . 2.2400000000000002 109.468 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.4 mt -113.26 104.33 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.227 -0.921 . . . . 1.76 109.503 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 2.5 ptt180 -90.81 179.83 5.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.259 -0.901 . . . . 2.6600000000000001 109.426 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.948 HG23 HD11 ' A' ' 69' ' ' ILE . 53.7 t -66.09 139.51 96.6 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.217 -0.927 . . . . 0.85999999999999999 109.401 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.661 ' HD2' HG13 ' A' ' 6' ' ' VAL . 35.5 Cg_endo -78.2 -170.32 0.95 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.739 2.293 . . . . 1.04 110.407 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -83.2 108.55 16.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.881 . . . . 1.74 109.4 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.596 HD11 HG11 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -107.69 -30.41 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.255 -0.903 . . . . 1.6799999999999999 109.4 -179.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.05 10.67 54.64 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.545 -1.422 . . . . 1.3999999999999999 109.545 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -170.87 -152.1 7.97 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.515 -1.434 . . . . 1.3500000000000001 109.515 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.402 ' OD1' ' HG3' ' A' ' 64' ' ' LYS . 2.1 m-20 -93.32 150.54 20.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -1.152 . . . . 2.2200000000000002 109.444 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -117.69 112.92 2.55 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.541 -1.423 . . . . 0.81999999999999995 109.541 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.516 ' CG ' ' HG2' ' A' ' 62' ' ' LYS . 1.3 mt-10 -99.64 127.79 45.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.247 -1.149 . . . . 2.6200000000000001 109.428 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.3 t -70.51 131.36 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.224 -0.923 . . . . 0.64000000000000001 109.462 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.41 ' HB ' ' O ' ' A' ' 34' ' ' VAL . 20.8 mm -102.06 -52.62 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 1.8200000000000001 109.472 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -145.8 164.07 33.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -0.9 . . . . 2.5600000000000001 109.456 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.14 114.81 18.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.332 -0.855 . . . . 1.5900000000000001 109.474 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.456 HD11 ' C ' ' A' ' 31' ' ' GLY . 0.4 OUTLIER -102.97 36.64 2.16 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.272 -0.892 . . . . 1.26 109.492 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.682 HG11 ' HG ' ' A' ' 32' ' ' LEU . 11.6 m -138.6 172.16 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.254 -0.904 . . . . 1.1200000000000001 109.482 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -146.71 176.85 9.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.277 -0.889 . . . . 2.6800000000000002 109.479 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.1 m -85.03 134.55 34.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.285 -0.884 . . . . 1.5600000000000001 109.466 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.61 -2.57 87.92 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.647 -1.381 . . . . 0.96999999999999997 109.647 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -84.97 131.54 34.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.211 -1.17 . . . . 1.52 109.507 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.674 HD12 ' HB ' ' A' ' 51' ' ' VAL . 0.4 OUTLIER -87.18 121.77 30.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.253 -0.904 . . . . 1.9299999999999999 109.452 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.752 HG22 ' H ' ' A' ' 27' ' ' GLU . 3.8 mt -94.05 -170.74 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 121.213 -0.93 . . . . 1.0600000000000001 109.355 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.752 ' H ' HG22 ' A' ' 26' ' ' ILE . 28.0 mt-10 -140.81 168.18 20.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.22 -0.925 . . . . 2.9300000000000002 109.481 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.733 ' O ' HG13 ' A' ' 28' ' ' VAL . 10.1 p -79.82 76.67 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.884 . . . . 1.5 109.439 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.537 ' CB ' ' O ' ' A' ' 28' ' ' VAL . 0.9 OUTLIER 161.53 -48.23 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.286 -0.884 . . . . 2.6299999999999999 109.457 179.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.416 ' O ' ' CB ' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -52.96 145.57 12.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.223 -0.923 . . . . 2.1800000000000002 109.465 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.456 ' C ' HD11 ' A' ' 19' ' ' LEU . . . -68.44 167.74 43.53 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.535 -1.426 . . . . 0.73999999999999999 109.535 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.682 ' HG ' HG11 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -128.41 -48.24 1.3 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -1.137 . . . . 1.71 109.505 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.6 m -145.68 171.25 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.294 -0.879 . . . . 0.81000000000000005 109.509 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.41 ' O ' ' HB ' ' A' ' 16' ' ' ILE . 95.9 t -128.34 92.38 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.278 -0.889 . . . . 0.70999999999999996 109.467 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 mt -90.02 146.55 24.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 1.21 109.453 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 41' ' ' SER . 35.9 tt0 -108.62 144.73 35.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -0.906 . . . . 2.27 109.473 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 40' ' ' ALA . 1.5 m -105.96 -173.79 2.38 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.281 -0.887 . . . . 1.6200000000000001 109.46 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.486 ' O ' ' HG3' ' A' ' 39' ' ' LYS . . . -85.02 -4.42 59.15 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.258 -0.901 . . . . 1.8700000000000001 109.694 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.703 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 22.2 mtpp -150.15 20.55 0.86 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.181 -0.95 . . . . 5.0899999999999999 109.679 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 39' ' ' LYS . . . 163.85 137.65 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.117 -0.99 . . . . 1.48 109.55 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.484 ' HA ' ' HA ' ' A' ' 36' ' ' GLU . 0.7 OUTLIER -95.58 133.58 39.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 1.6499999999999999 109.466 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 8.8 mtt -117.63 157.09 27.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.9 . . . . 3.21 109.451 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -114.77 154.62 28.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.283 -0.886 . . . . 2.1099999999999999 109.449 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.496 ' O ' ' CB ' ' A' ' 32' ' ' LEU . 21.7 t -130.64 110.74 16.12 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.293 -0.879 . . . . 1.1899999999999999 109.37 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.501 ' HA ' ' N ' ' A' ' 32' ' ' LEU . 35.6 Cg_endo -77.82 -168.32 0.59 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.629 2.219 . . . . 0.81999999999999995 110.47 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.538 ' HB2' HG21 ' A' ' 26' ' ' ILE . 2.0 t -85.17 120.79 73.78 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 0.94999999999999996 109.537 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.02 -0.5 10.73 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.636 2.224 . . . . 1.3100000000000001 110.291 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -160.14 138.5 10.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.364 -0.835 . . . . 3.1299999999999999 109.396 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -80.48 92.2 5.85 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.224 -0.922 . . . . 1.4299999999999999 109.463 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.731 ' N ' HD11 ' A' ' 72' ' ' LEU . . . -142.83 -164.55 10.22 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.548 -1.421 . . . . 1.2 109.548 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.674 ' HB ' HD12 ' A' ' 25' ' ' LEU . 7.8 p -117.24 122.68 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.262 -1.14 . . . . 1.0800000000000001 109.496 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.413 ' C ' ' O ' ' A' ' 51' ' ' VAL . 72.8 t -44.11 137.71 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.269 -0.894 . . . . 0.79000000000000004 109.432 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.413 ' HD2' ' OE1' ' A' ' 73' ' ' GLU . 14.1 tttp -113.72 -41.14 3.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.918 . . . . 2.4900000000000002 109.45 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.64 144.37 17.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.236 -0.915 . . . . 1.6699999999999999 109.472 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.54 HG12 ' H ' ' A' ' 57' ' ' VAL . 39.7 t -106.42 111.72 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.307 -0.871 . . . . 0.95999999999999996 109.457 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.3 m -90.2 17.15 7.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.213 -0.929 . . . . 1.3999999999999999 109.448 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.54 ' H ' HG12 ' A' ' 55' ' ' VAL . 28.6 m -140.61 179.85 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.896 . . . . 1.1200000000000001 109.493 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -141.93 175.03 10.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.304 -0.873 . . . . 3.1600000000000001 109.508 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.84 129.43 34.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.254 -0.904 . . . . 1.2 109.494 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.26 -11.46 72.08 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.511 -1.436 . . . . 0.83999999999999997 109.511 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.83 157.06 35.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -1.148 . . . . 1.52 109.495 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.516 ' HG2' ' CG ' ' A' ' 14' ' ' GLU . 25.6 mtpt -106.63 143.62 34.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.276 -0.89 . . . . 3.4900000000000002 109.47 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 62' ' ' LYS . 3.7 mt -140.89 141.81 34.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 2.0 109.513 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.455 ' O ' ' C ' ' A' ' 65' ' ' GLU . 1.7 tttt -98.66 140.73 32.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.271 -0.893 . . . . 2.4199999999999999 109.47 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.476 ' HA ' ' HB ' ' A' ' 6' ' ' VAL . 9.7 pt-20 -41.13 139.77 0.9 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.327 -0.858 . . . . 2.6099999999999999 109.634 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.41 -15.72 59.77 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.547 -1.421 . . . . 0.94999999999999996 109.547 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.06 140.32 31.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.212 -1.169 . . . . 1.4299999999999999 109.5 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.96 150.79 41.35 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.217 -0.927 . . . . 0.69999999999999996 109.41 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.948 HD11 HG23 ' A' ' 6' ' ' VAL . 28.1 mm -115.04 -66.39 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.206 -0.934 . . . . 1.3 109.456 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.403 HG23 HG22 ' A' ' 69' ' ' ILE . 1.2 pt -142.43 177.1 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.286 -0.884 . . . . 1.23 109.46 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -129.85 104.72 7.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.18 -0.95 . . . . 2.1299999999999999 109.446 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.84 HD23 ' HD3' ' A' ' 74' ' ' PRO . 2.8 tt -90.0 144.01 26.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.232 -0.917 . . . . 1.4099999999999999 109.404 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.413 ' OE1' ' HD2' ' A' ' 53' ' ' LYS . 46.9 tt0 -112.21 94.65 27.06 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.271 -0.893 . . . . 2.1800000000000002 109.457 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.84 ' HD3' HD23 ' A' ' 72' ' ' LEU . 35.6 Cg_endo -77.64 78.58 3.47 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.743 2.296 . . . . 2.02 110.428 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -45.96 98.24 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.255 -0.903 . . . . 2.2400000000000002 109.493 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 74' ' ' PRO . . . -86.13 58.45 5.06 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.891 . . . . 3.79 109.436 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.515 ' O ' ' N ' ' A' ' 79' ' ' ARG . . . 88.44 -64.73 3.47 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.474 -1.451 . . . . 4.8300000000000001 109.474 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 47.49 -93.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.252 -1.146 . . . . 6.5999999999999996 109.451 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.515 ' N ' ' O ' ' A' ' 77' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 118.038 -0.982 . . . . 10.789999999999999 109.441 -179.939 . . . . . . . . 2 2 . 1 stop_ save_